Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-Coding RNAs (lncRNAs) in OncologyBusiness Wire • 08/28/24
Fast, Stable, Secure: New Bayer Hardware Simplifies Farm Activities, Equipment Setup and Provides Increased Value to FarmersBusiness Wire • 08/26/24
Bayer (BAYRY) Starts Mid-Stage Study on Chronic Kidney Disease DrugZacks Investment Research • 08/23/24
Bayer Initiates Phase II Study of Soluble Guanylate Cyclase Activator (BAY3283142) in Patients With Chronic Kidney DiseaseBusiness Wire • 08/22/24
Bayer shares surge 10% after major legal victory in Roundup cancer litigation: Time to buy?Invezz • 08/16/24
Bayer's stock surges after U.S. appeals court strikes down Roundup cancer caseMarket Watch • 08/16/24
Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular Outcomes Study Investigating KERENDIA® (finerenone) in Patients with Heart Failure with Mildly Reduced or Preserved Ejection FractionBusiness Wire • 08/05/24
Bayer Submits New Drug Application to U.S. FDA for Elinzanetant for the Treatment of Moderate to Severe Vasomotor Symptoms Associated With MenopauseBusiness Wire • 08/01/24
Australian judge dismisses lawsuit claiming Bayer's Roundup weedkiller causes cancerReuters • 07/25/24
Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC)Business Wire • 07/17/24
Bayer and Kroger Team Up with Luke Bryan and Feeding America to Improve Access to Nutritious FoodBusiness Wire • 07/13/24